Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

Rangering i aksjer #2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Aksjekurs
$100.60
Markedsverdi
$7.54B
Endring (1 dag)
-1.49%
Endring (1 år)
49.53%
Land
CH
Handel Bachem Holding AG (BANB)

Kategori

Healthcare
Utbytteavkastning for Bachem Holding AG (BANB)
Bachem Holding AG (aksjesymbol: BANB) sin utbytteavkastning (TTM) per 2024-12-31 er: 1.38%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.86%
Utbytteavkastning for Bachem Holding AG (BANB) fra 2002 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
2026 (TTM) 1.08% 58.82%
2025 0.68% -50.72%
2024 1.38% 18.97%
2023 1.16% 31.82%
2022 0.88% 340.00%
2021 0.20% -73.68%
2020 0.76% -40.63%
2019 1.28% -27.27%
2018 1.76% 53.04%
2017 1.15% -31.14%
2016 1.67% -31.28%
2015 2.43% -31.93%
2014 3.57% 15.53%
2013 3.09% 50.73%
2012 2.05% -46.19%
2011 3.81% 43.77%
2010 2.65% 11.34%
2009 2.38% -36.36%
2008 3.74% -48.84%
2007 7.31% 348.47%
2006 1.63% 409.38%
2005 0.32% -81.07%
2004 1.69% -92.16%
2003 21.55% -99.40%
2002 3,618.76% 0.00%
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
0.00%
US
0.00%
US
2.07%
AU
0.00%
NL
0.00%
CH